Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism

Alcohol abuse is a leading risk factor for the public health burden worldwide. Approved pharmacotherapies have demonstrated limited effectiveness over the last few decades in treating alcohol use disorders (AUD). New therapeutic approaches are therefore urgently needed. Historical and recent clinica...

Full description

Bibliographic Details
Main Authors:	Kevin Domanegg, Wolfgang H. Sommer, Marcus W. Meinhardt
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Cells
Subjects:	alcohol addiction metabotropic glutamate receptors serotonin 2a receptors psychedelics psilocybin functional selectivity
Online Access:	https://www.mdpi.com/2073-4409/12/6/963

Similar Items

Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
by: Marvin M. Urban, et al.
Published: (2023-04-01)

Role of Metabotropic Glutamate Receptors in Neurological Disorders
by: Rosalia Crupi, et al.
Published: (2019-02-01)

Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics
by: Stephanie Karzon Abrams, et al.
Published: (2023-08-01)

Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
by: Henry Lowe, et al.
Published: (2022-04-01)

Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation
by: Mariacristina Mazzitelli, et al.
Published: (2018-10-01)

Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression
by: Kevinn Eddy, et al.
Published: (2022-09-01)

The Lateral Metalation of Isoxazolo[3,4-<i>d</i>]pyridazinones towards Hit-to-Lead Development of Selective Positive Modulators of Metabotropic Glutamate Receptors
by: Christina A. Gates, et al.
Published: (2023-09-01)

Complex formation and functional interaction between adenosine A1 receptor and type-1 metabotropic glutamate receptor
by: Yuji Kamikubo, et al.
Published: (2015-07-01)

Differential expression of metabotropic glutamate and GABAB receptors at neocortical glutamatergic and GABAergic axon terminals
by: Luca eBragina, et al.
Published: (2015-09-01)

Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor
by: Kouji Fukuyama, et al.
Published: (2019-06-01)

Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate levels and neurocognition in non-smoking, active alcoholics
by: Xia Yan, et al.
Published: (2012-08-01)

Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors
by: Mariacristina Mazzitelli, et al.
Published: (2022-08-01)

Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain
by: Caroline eMénard, et al.
Published: (2012-10-01)

Psychedelics and psychiatric disorders: A emerging role
by: C. Peixoto, et al.
Published: (2021-04-01)

Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
by: Fúlvio Rieli Mendes, et al.
Published: (2022-09-01)

The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences
by: Tomas Frymann, et al.
Published: (2022-05-01)

Metabotropic Glutamate Receptors 1 Regulates Rat Carotid Body Response to Acute Hypoxia via Presynaptic Mechanism
by: Chaohong Li, et al.
Published: (2021-10-01)

Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
by: Brian S. Barnett, et al.
Published: (2023-10-01)

Anti‐metabotropic glutamate receptor 5 encephalitis: Five case reports and literature review
by: Sixian Chen, et al.
Published: (2023-05-01)

Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders
by: Richard M. Cleva, et al.
Published: (2011-03-01)

Metabotropic Glutamate Receptors at Ribbon Synapses in the Retina and Cochlea
by: Lisa Klotz-Weigand, et al.
Published: (2022-03-01)

Development of a digital intervention for psychedelic preparation (DIPP)
by: Rosalind G. McAlpine, et al.
Published: (2024-02-01)

The sigma1 receptor agonist enhances long-term depression caused by activation of metabotropic glutamate receptors in rat hippocampal neurons
by: Pavel D. Rogozin, et al.
Published: (2018-12-01)

Group I metabotropic glutamate receptors (mGluR1/5) and neurodegenerative diseases
by: Elena I. Solntseva, et al.
Published: (2019-12-01)

Orthogonal Activation of Metabotropic Glutamate Receptor Using Coordination Chemogenetics
by: Akinobu Senoo, et al.
Published: (2022-01-01)

Early Effects of the Soluble Amyloid β<sub>25-35</sub> Peptide in Rat Cortical Neurons: Modulation of Signal Transduction Mediated by Adenosine and Group I Metabotropic Glutamate Receptors
by: Carlos Alberto Castillo, et al.
Published: (2021-06-01)

New Paradigms of Old Psychedelics in Schizophrenia
by: Danish Mahmood, et al.
Published: (2022-05-01)

Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception
by: Crock Lara W, et al.
Published: (2012-03-01)

A metabotropic glutamate receptor affects the growth and development of Schistosoma japonicum
by: Xiaoling Wang, et al.
Published: (2022-11-01)

Critical role of metabotropic glutamate receptor 4 in bone marrow-derived dendritic cells in the Th17 cell differentiation and the melanogenesis of B16 cells
by: Guangming Zhao, et al.
Published: (2020-04-01)

Metabotropic glutamate receptor 5 (mGluR5) regulates white adipocyte browning
by: LUO Xie, ZENG Li, YUAN Lei
Published: (2021-01-01)

Dendritic signaling in inhibitory interneurons: local tuning via group I metabotropic glutamate receptors
by: Olivier eCamiré, et al.
Published: (2012-07-01)

Adenosine and Metabotropic Glutamate Receptors Are Present in Blood Serum and Exosomes from SAMP8 Mice: Modulation by Aging and Resveratrol
by: Alejandro Sánchez-Melgar, et al.
Published: (2020-07-01)

The Role of Glutamate Receptors in Epilepsy
by: Tsang-Shan Chen, et al.
Published: (2023-03-01)

Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
by: Simona Federica Spampinato, et al.
Published: (2018-11-01)

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey
by: Nicolas G. Glynos, et al.
Published: (2024-02-01)

Henri Michaux's program for the psychedelic humanities
by: Oliver Davis
Published: (2023-05-01)

Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications
by: Orr Shahar, et al.
Published: (2022-11-01)

Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders
by: Grace Blest-Hopley, et al.
Published: (2023-05-01)

Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications
by: Leyi Huang, et al.
Published: (2024-01-01)